← Open Payments lookup

KRISTIN LEHMANN: Open Payments

NPI 1558951988 · RICHMOND, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$960 in 58 payments from 11 companies in 2025. Trend: 2023 $572 · 2024 $521 · 2025 $960

Food & beverage: $960
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)32$268
Otsuka America Pharmaceutical, Inc.8$226
Neurocrine BioSciences, Inc.3$187
Takeda Pharmaceuticals U.S.A., Inc.3$60
Axsome Therapeutics, Inc.2$53
Lundbeck LLC3$50
Teva Pharmaceuticals USA, Inc.2$36
Collegium Pharmaceutical, Inc.2$36
Janssen Pharmaceuticals, Inc1$15
E.R. Squibb & Sons, L.L.C.1$14

Products named: REXULTI, CAPLYTA, INGREZZA, TRINTELLIX, Auvelity, AUSTEDO XR, Jornay PM, SPRAVATO.

Industry payments across VA — which companies pay providers there.